nodes	percent_of_prediction	percent_of_DWPC	metapath
Dronedarone—CYP3A4—prostate cancer	0.0871	1	CbGaD
Dronedarone—ALB—Abiraterone—prostate cancer	0.0454	0.0991	CbGbCtD
Dronedarone—ALB—Estrone—prostate cancer	0.0328	0.0717	CbGbCtD
Dronedarone—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0327	0.0714	CbGbCtD
Dronedarone—CYP2D6—Bicalutamide—prostate cancer	0.027	0.059	CbGbCtD
Dronedarone—ABCB1—Estramustine—prostate cancer	0.0266	0.0582	CbGbCtD
Dronedarone—CYP2D6—Abiraterone—prostate cancer	0.0224	0.0488	CbGbCtD
Dronedarone—ALB—Estradiol—prostate cancer	0.0188	0.0412	CbGbCtD
Dronedarone—ADRA1B—vas deferens—prostate cancer	0.0187	0.209	CbGeAlD
Dronedarone—ABCB1—Cabazitaxel—prostate cancer	0.0176	0.0383	CbGbCtD
Dronedarone—CYP3A4—Bicalutamide—prostate cancer	0.0172	0.0375	CbGbCtD
Dronedarone—ABCB1—Estrone—prostate cancer	0.0172	0.0375	CbGbCtD
Dronedarone—ALB—Prednisone—prostate cancer	0.0162	0.0354	CbGbCtD
Dronedarone—CYP3A4—Estramustine—prostate cancer	0.016	0.0348	CbGbCtD
Dronedarone—ABCB1—Ethinyl Estradiol—prostate cancer	0.0153	0.0334	CbGbCtD
Dronedarone—CYP3A4—Abiraterone—prostate cancer	0.0142	0.0311	CbGbCtD
Dronedarone—CYP3A4—Flutamide—prostate cancer	0.0142	0.0311	CbGbCtD
Dronedarone—ABCB1—Conjugated Estrogens—prostate cancer	0.0112	0.0245	CbGbCtD
Dronedarone—CYP3A4—Cabazitaxel—prostate cancer	0.0105	0.023	CbGbCtD
Dronedarone—CYP3A4—Estrone—prostate cancer	0.0103	0.0225	CbGbCtD
Dronedarone—ABCB1—Mitoxantrone—prostate cancer	0.0102	0.0223	CbGbCtD
Dronedarone—ABCB1—Estradiol—prostate cancer	0.00986	0.0215	CbGbCtD
Dronedarone—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00916	0.02	CbGbCtD
Dronedarone—ABCB1—Prednisone—prostate cancer	0.00848	0.0185	CbGbCtD
Dronedarone—CYP3A4—Conjugated Estrogens—prostate cancer	0.00673	0.0147	CbGbCtD
Dronedarone—ABCB1—Etoposide—prostate cancer	0.00644	0.0141	CbGbCtD
Dronedarone—CYP3A4—Mitoxantrone—prostate cancer	0.00611	0.0134	CbGbCtD
Dronedarone—CYP3A4—Estradiol—prostate cancer	0.00591	0.0129	CbGbCtD
Dronedarone—ABCB1—Docetaxel—prostate cancer	0.00589	0.0129	CbGbCtD
Dronedarone—CYP3A4—Prednisone—prostate cancer	0.00508	0.0111	CbGbCtD
Dronedarone—ABCB1—Doxorubicin—prostate cancer	0.00439	0.00959	CbGbCtD
Dronedarone—CYP2D6—Doxorubicin—prostate cancer	0.00414	0.00903	CbGbCtD
Dronedarone—CYP3A4—Etoposide—prostate cancer	0.00386	0.00842	CbGbCtD
Dronedarone—CACNB4—prostate gland—prostate cancer	0.00366	0.041	CbGeAlD
Dronedarone—CYP3A4—Docetaxel—prostate cancer	0.00353	0.00771	CbGbCtD
Dronedarone—KCNK2—prostate gland—prostate cancer	0.00325	0.0363	CbGeAlD
Dronedarone—HCN4—testis—prostate cancer	0.00324	0.0362	CbGeAlD
Dronedarone—CACNB1—prostate gland—prostate cancer	0.00293	0.0327	CbGeAlD
Dronedarone—CACNB3—prostate gland—prostate cancer	0.00281	0.0314	CbGeAlD
Dronedarone—CACNA1S—seminal vesicle—prostate cancer	0.00265	0.0297	CbGeAlD
Dronedarone—CYP3A4—Doxorubicin—prostate cancer	0.00263	0.00574	CbGbCtD
Dronedarone—HCN3—testis—prostate cancer	0.00262	0.0293	CbGeAlD
Dronedarone—HCN2—testis—prostate cancer	0.00245	0.0274	CbGeAlD
Dronedarone—CACNB3—seminal vesicle—prostate cancer	0.00237	0.0265	CbGeAlD
Dronedarone—CACNB2—prostate gland—prostate cancer	0.00189	0.0211	CbGeAlD
Dronedarone—CACNB3—urethra—prostate cancer	0.00188	0.021	CbGeAlD
Dronedarone—CACNA1D—prostate gland—prostate cancer	0.00165	0.0184	CbGeAlD
Dronedarone—ADRA1D—prostate gland—prostate cancer	0.00163	0.0183	CbGeAlD
Dronedarone—CACNB4—testis—prostate cancer	0.00161	0.018	CbGeAlD
Dronedarone—CYP3A4—urine—prostate cancer	0.00156	0.0175	CbGeAlD
Dronedarone—CYP2D6—urine—prostate cancer	0.00154	0.0172	CbGeAlD
Dronedarone—CACNA1C—prostate gland—prostate cancer	0.00152	0.017	CbGeAlD
Dronedarone—KCNK2—testis—prostate cancer	0.00143	0.016	CbGeAlD
Dronedarone—CACNB1—testis—prostate cancer	0.00129	0.0144	CbGeAlD
Dronedarone—CACNB3—testis—prostate cancer	0.00124	0.0138	CbGeAlD
Dronedarone—ADRA1D—epithelium—prostate cancer	0.0012	0.0134	CbGeAlD
Dronedarone—ADRB1—prostate gland—prostate cancer	0.00119	0.0133	CbGeAlD
Dronedarone—ADRA1B—renal system—prostate cancer	0.00114	0.0127	CbGeAlD
Dronedarone—ADRA1D—urethra—prostate cancer	0.00109	0.0122	CbGeAlD
Dronedarone—KCNK2—lymph node—prostate cancer	0.00104	0.0116	CbGeAlD
Dronedarone—ADRA1A—prostate gland—prostate cancer	0.000939	0.0105	CbGeAlD
Dronedarone—CACNB1—lymph node—prostate cancer	0.000934	0.0104	CbGeAlD
Dronedarone—KCNH2—prostate gland—prostate cancer	0.000906	0.0101	CbGeAlD
Dronedarone—CACNB3—lymph node—prostate cancer	0.000896	0.01	CbGeAlD
Dronedarone—ADRA2C—prostate gland—prostate cancer	0.000894	0.01	CbGeAlD
Dronedarone—CACNB2—testis—prostate cancer	0.000831	0.00929	CbGeAlD
Dronedarone—Dofetilide—CYP3A4—prostate cancer	0.000829	0.24	CrCbGaD
Dronedarone—KCNH2—seminal vesicle—prostate cancer	0.000767	0.00857	CbGeAlD
Dronedarone—ADRA2C—seminal vesicle—prostate cancer	0.000756	0.00846	CbGeAlD
Dronedarone—CACNA1D—testis—prostate cancer	0.000726	0.00812	CbGeAlD
Dronedarone—ADRA2A—prostate gland—prostate cancer	0.000714	0.00798	CbGeAlD
Dronedarone—Amiodarone—CYP3A5—prostate cancer	0.000698	0.202	CrCbGaD
Dronedarone—ADRA1A—epithelium—prostate cancer	0.00069	0.00771	CbGeAlD
Dronedarone—Amiodarone—CYP2A6—prostate cancer	0.000675	0.196	CrCbGaD
Dronedarone—CACNA1C—testis—prostate cancer	0.00067	0.00749	CbGeAlD
Dronedarone—ADRA1A—renal system—prostate cancer	0.00064	0.00715	CbGeAlD
Dronedarone—KCNH2—renal system—prostate cancer	0.000618	0.00691	CbGeAlD
Dronedarone—ADRA2C—renal system—prostate cancer	0.00061	0.00682	CbGeAlD
Dronedarone—KCNH2—urethra—prostate cancer	0.000607	0.00679	CbGeAlD
Dronedarone—ADRA2A—seminal vesicle—prostate cancer	0.000604	0.00675	CbGeAlD
Dronedarone—CACNB2—lymph node—prostate cancer	0.000602	0.00673	CbGeAlD
Dronedarone—ADRA2C—urethra—prostate cancer	0.000599	0.0067	CbGeAlD
Dronedarone—CACNA1D—lymph node—prostate cancer	0.000526	0.00588	CbGeAlD
Dronedarone—ALB—testis—prostate cancer	0.00052	0.00581	CbGeAlD
Dronedarone—CACNA1C—lymph node—prostate cancer	0.000486	0.00543	CbGeAlD
Dronedarone—ADRA2A—urethra—prostate cancer	0.000478	0.00534	CbGeAlD
Dronedarone—Amiodarone—CYP2C19—prostate cancer	0.000475	0.138	CrCbGaD
Dronedarone—Amiodarone—CYP1A1—prostate cancer	0.000473	0.137	CrCbGaD
Dronedarone—KCNH2—bone marrow—prostate cancer	0.000467	0.00522	CbGeAlD
Dronedarone—KCNH2—testis—prostate cancer	0.000399	0.00447	CbGeAlD
Dronedarone—ABCB1—prostate gland—prostate cancer	0.000398	0.00445	CbGeAlD
Dronedarone—ADRA2C—testis—prostate cancer	0.000394	0.00441	CbGeAlD
Dronedarone—CYP3A4—renal system—prostate cancer	0.000383	0.00428	CbGeAlD
Dronedarone—ALB—lymph node—prostate cancer	0.000377	0.00421	CbGeAlD
Dronedarone—CYP2D6—renal system—prostate cancer	0.000377	0.00421	CbGeAlD
Dronedarone—ABCB1—seminal vesicle—prostate cancer	0.000336	0.00376	CbGeAlD
Dronedarone—Vomiting—Cabazitaxel—prostate cancer	0.000333	0.00194	CcSEcCtD
Dronedarone—Cardiac failure—Docetaxel—prostate cancer	0.000333	0.00194	CcSEcCtD
Dronedarone—Liver injury—Doxorubicin—prostate cancer	0.000332	0.00193	CcSEcCtD
Dronedarone—Bradycardia—Mitoxantrone—prostate cancer	0.000331	0.00193	CcSEcCtD
Dronedarone—Nausea—Degarelix—prostate cancer	0.000331	0.00192	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Ethinyl Estradiol—prostate cancer	0.000328	0.00191	CcSEcCtD
Dronedarone—Fatigue—Ethinyl Estradiol—prostate cancer	0.000328	0.00191	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Goserelin—prostate cancer	0.000324	0.00189	CcSEcCtD
Dronedarone—Cardiac disorder—Estradiol—prostate cancer	0.000324	0.00189	CcSEcCtD
Dronedarone—Asthenia—Bicalutamide—prostate cancer	0.000323	0.00188	CcSEcCtD
Dronedarone—Cardiac failure—Capecitabine—prostate cancer	0.000323	0.00188	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—prostate cancer	0.000321	0.00187	CcSEcCtD
Dronedarone—Pruritus—Bicalutamide—prostate cancer	0.000318	0.00185	CcSEcCtD
Dronedarone—Angiopathy—Estradiol—prostate cancer	0.000317	0.00184	CcSEcCtD
Dronedarone—Immune system disorder—Estradiol—prostate cancer	0.000315	0.00184	CcSEcCtD
Dronedarone—Mediastinal disorder—Estradiol—prostate cancer	0.000315	0.00183	CcSEcCtD
Dronedarone—ADRA2A—testis—prostate cancer	0.000314	0.00352	CbGeAlD
Dronedarone—Anaphylactic shock—Goserelin—prostate cancer	0.000313	0.00182	CcSEcCtD
Dronedarone—Nausea—Cabazitaxel—prostate cancer	0.000312	0.00181	CcSEcCtD
Dronedarone—Gastrointestinal pain—Ethinyl Estradiol—prostate cancer	0.000311	0.00181	CcSEcCtD
Dronedarone—Anaphylactic shock—Conjugated Estrogens—prostate cancer	0.00031	0.0018	CcSEcCtD
Dronedarone—Cardiac failure congestive—Prednisone—prostate cancer	0.000309	0.0018	CcSEcCtD
Dronedarone—Diarrhoea—Bicalutamide—prostate cancer	0.000308	0.00179	CcSEcCtD
Dronedarone—Nervous system disorder—Goserelin—prostate cancer	0.000307	0.00179	CcSEcCtD
Dronedarone—Nervous system disorder—Conjugated Estrogens—prostate cancer	0.000304	0.00177	CcSEcCtD
Dronedarone—Erythema—Estradiol—prostate cancer	0.000304	0.00177	CcSEcCtD
Dronedarone—Skin disorder—Goserelin—prostate cancer	0.000304	0.00177	CcSEcCtD
Dronedarone—Pneumonia—Etoposide—prostate cancer	0.000303	0.00176	CcSEcCtD
Dronedarone—Amiodarone—CYP3A4—prostate cancer	0.000302	0.0875	CrCbGaD
Dronedarone—Skin disorder—Conjugated Estrogens—prostate cancer	0.000301	0.00175	CcSEcCtD
Dronedarone—Abdominal pain—Ethinyl Estradiol—prostate cancer	0.000301	0.00175	CcSEcCtD
Dronedarone—Dysgeusia—Estradiol—prostate cancer	0.000298	0.00173	CcSEcCtD
Dronedarone—Blood creatinine increased—Capecitabine—prostate cancer	0.000295	0.00172	CcSEcCtD
Dronedarone—ABCB1—epithelium—prostate cancer	0.000292	0.00327	CbGeAlD
Dronedarone—KCNH2—lymph node—prostate cancer	0.000289	0.00324	CbGeAlD
Dronedarone—Cardiac failure—Prednisone—prostate cancer	0.000287	0.00167	CcSEcCtD
Dronedarone—Hypokalaemia—Capecitabine—prostate cancer	0.000286	0.00167	CcSEcCtD
Dronedarone—Vomiting—Bicalutamide—prostate cancer	0.000286	0.00166	CcSEcCtD
Dronedarone—ADRA2C—lymph node—prostate cancer	0.000286	0.00319	CbGeAlD
Dronedarone—Hepatobiliary disease—Etoposide—prostate cancer	0.000285	0.00166	CcSEcCtD
Dronedarone—Rash—Bicalutamide—prostate cancer	0.000284	0.00165	CcSEcCtD
Dronedarone—Dermatitis—Bicalutamide—prostate cancer	0.000283	0.00165	CcSEcCtD
Dronedarone—Erythema—Mitoxantrone—prostate cancer	0.000283	0.00165	CcSEcCtD
Dronedarone—Angioedema—Estradiol—prostate cancer	0.000278	0.00162	CcSEcCtD
Dronedarone—Dysgeusia—Mitoxantrone—prostate cancer	0.000277	0.00161	CcSEcCtD
Dronedarone—Dyspepsia—Goserelin—prostate cancer	0.000275	0.0016	CcSEcCtD
Dronedarone—Dyspepsia—Conjugated Estrogens—prostate cancer	0.000273	0.00159	CcSEcCtD
Dronedarone—Asthenia—Ethinyl Estradiol—prostate cancer	0.000273	0.00159	CcSEcCtD
Dronedarone—ABCB1—renal system—prostate cancer	0.000271	0.00303	CbGeAlD
Dronedarone—Fatigue—Goserelin—prostate cancer	0.00027	0.00157	CcSEcCtD
Dronedarone—Pruritus—Ethinyl Estradiol—prostate cancer	0.000269	0.00157	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Conjugated Estrogens—prostate cancer	0.000268	0.00156	CcSEcCtD
Dronedarone—Fatigue—Conjugated Estrogens—prostate cancer	0.000267	0.00156	CcSEcCtD
Dronedarone—Nausea—Bicalutamide—prostate cancer	0.000267	0.00156	CcSEcCtD
Dronedarone—ABCB1—urethra—prostate cancer	0.000266	0.00298	CbGeAlD
Dronedarone—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.00026	0.00151	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Estradiol—prostate cancer	0.000257	0.0015	CcSEcCtD
Dronedarone—Gastrointestinal pain—Goserelin—prostate cancer	0.000256	0.00149	CcSEcCtD
Dronedarone—Hypokalaemia—Prednisone—prostate cancer	0.000255	0.00149	CcSEcCtD
Dronedarone—Gastrointestinal pain—Conjugated Estrogens—prostate cancer	0.000253	0.00148	CcSEcCtD
Dronedarone—Pneumonia—Docetaxel—prostate cancer	0.000252	0.00147	CcSEcCtD
Dronedarone—Cardiac disorder—Etoposide—prostate cancer	0.000251	0.00146	CcSEcCtD
Dronedarone—Photosensitivity reaction—Capecitabine—prostate cancer	0.000248	0.00145	CcSEcCtD
Dronedarone—Anaphylactic shock—Estradiol—prostate cancer	0.000248	0.00144	CcSEcCtD
Dronedarone—Abdominal pain—Goserelin—prostate cancer	0.000247	0.00144	CcSEcCtD
Dronedarone—Angiopathy—Etoposide—prostate cancer	0.000246	0.00143	CcSEcCtD
Dronedarone—Abdominal pain—Conjugated Estrogens—prostate cancer	0.000245	0.00143	CcSEcCtD
Dronedarone—Immune system disorder—Etoposide—prostate cancer	0.000244	0.00142	CcSEcCtD
Dronedarone—Eczema—Epirubicin—prostate cancer	0.000244	0.00142	CcSEcCtD
Dronedarone—Pneumonia—Capecitabine—prostate cancer	0.000244	0.00142	CcSEcCtD
Dronedarone—Mediastinal disorder—Etoposide—prostate cancer	0.000244	0.00142	CcSEcCtD
Dronedarone—CYP2D6—testis—prostate cancer	0.000244	0.00272	CbGeAlD
Dronedarone—Nervous system disorder—Estradiol—prostate cancer	0.000243	0.00142	CcSEcCtD
Dronedarone—Cardiac failure congestive—Epirubicin—prostate cancer	0.000242	0.00141	CcSEcCtD
Dronedarone—Vomiting—Ethinyl Estradiol—prostate cancer	0.000242	0.00141	CcSEcCtD
Dronedarone—Skin disorder—Estradiol—prostate cancer	0.000241	0.0014	CcSEcCtD
Dronedarone—Rash—Ethinyl Estradiol—prostate cancer	0.00024	0.0014	CcSEcCtD
Dronedarone—Dermatitis—Ethinyl Estradiol—prostate cancer	0.00024	0.00139	CcSEcCtD
Dronedarone—Hepatobiliary disease—Docetaxel—prostate cancer	0.000237	0.00138	CcSEcCtD
Dronedarone—Anaphylactic shock—Mitoxantrone—prostate cancer	0.000231	0.00135	CcSEcCtD
Dronedarone—Dysgeusia—Etoposide—prostate cancer	0.000231	0.00134	CcSEcCtD
Dronedarone—Hepatobiliary disease—Capecitabine—prostate cancer	0.000229	0.00134	CcSEcCtD
Dronedarone—ADRA2A—lymph node—prostate cancer	0.000228	0.00255	CbGeAlD
Dronedarone—Nausea—Ethinyl Estradiol—prostate cancer	0.000226	0.00131	CcSEcCtD
Dronedarone—Eczema—Doxorubicin—prostate cancer	0.000226	0.00131	CcSEcCtD
Dronedarone—Cardiac failure—Epirubicin—prostate cancer	0.000225	0.00131	CcSEcCtD
Dronedarone—Asthenia—Goserelin—prostate cancer	0.000225	0.00131	CcSEcCtD
Dronedarone—Skin disorder—Mitoxantrone—prostate cancer	0.000225	0.00131	CcSEcCtD
Dronedarone—Cardiac failure congestive—Doxorubicin—prostate cancer	0.000224	0.0013	CcSEcCtD
Dronedarone—Asthenia—Conjugated Estrogens—prostate cancer	0.000222	0.00129	CcSEcCtD
Dronedarone—Bradycardia—Capecitabine—prostate cancer	0.000222	0.00129	CcSEcCtD
Dronedarone—Pruritus—Goserelin—prostate cancer	0.000221	0.00129	CcSEcCtD
Dronedarone—Pruritus—Conjugated Estrogens—prostate cancer	0.000219	0.00128	CcSEcCtD
Dronedarone—Dyspepsia—Estradiol—prostate cancer	0.000218	0.00127	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Estradiol—prostate cancer	0.000214	0.00125	CcSEcCtD
Dronedarone—Diarrhoea—Goserelin—prostate cancer	0.000214	0.00125	CcSEcCtD
Dronedarone—Fatigue—Estradiol—prostate cancer	0.000214	0.00124	CcSEcCtD
Dronedarone—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000212	0.00123	CcSEcCtD
Dronedarone—Cardiac disorder—Docetaxel—prostate cancer	0.000209	0.00122	CcSEcCtD
Dronedarone—Cardiac failure—Doxorubicin—prostate cancer	0.000208	0.00121	CcSEcCtD
Dronedarone—Blood creatinine increased—Epirubicin—prostate cancer	0.000205	0.0012	CcSEcCtD
Dronedarone—ABCB1—bone marrow—prostate cancer	0.000205	0.00229	CbGeAlD
Dronedarone—Angiopathy—Docetaxel—prostate cancer	0.000204	0.00119	CcSEcCtD
Dronedarone—Dyspepsia—Mitoxantrone—prostate cancer	0.000203	0.00118	CcSEcCtD
Dronedarone—Immune system disorder—Docetaxel—prostate cancer	0.000203	0.00118	CcSEcCtD
Dronedarone—Gastrointestinal pain—Estradiol—prostate cancer	0.000203	0.00118	CcSEcCtD
Dronedarone—Mediastinal disorder—Docetaxel—prostate cancer	0.000203	0.00118	CcSEcCtD
Dronedarone—Cardiac disorder—Capecitabine—prostate cancer	0.000202	0.00118	CcSEcCtD
Dronedarone—Hypokalaemia—Epirubicin—prostate cancer	0.0002	0.00116	CcSEcCtD
Dronedarone—Fatigue—Mitoxantrone—prostate cancer	0.000199	0.00116	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	0.000199	0.00116	CcSEcCtD
Dronedarone—Vomiting—Goserelin—prostate cancer	0.000199	0.00116	CcSEcCtD
Dronedarone—Angiopathy—Capecitabine—prostate cancer	0.000198	0.00115	CcSEcCtD
Dronedarone—Bradycardia—Prednisone—prostate cancer	0.000197	0.00115	CcSEcCtD
Dronedarone—Rash—Goserelin—prostate cancer	0.000197	0.00115	CcSEcCtD
Dronedarone—Dermatitis—Goserelin—prostate cancer	0.000197	0.00115	CcSEcCtD
Dronedarone—Vomiting—Conjugated Estrogens—prostate cancer	0.000197	0.00115	CcSEcCtD
Dronedarone—Immune system disorder—Capecitabine—prostate cancer	0.000197	0.00114	CcSEcCtD
Dronedarone—Mediastinal disorder—Capecitabine—prostate cancer	0.000196	0.00114	CcSEcCtD
Dronedarone—Abdominal pain—Estradiol—prostate cancer	0.000196	0.00114	CcSEcCtD
Dronedarone—Erythema—Docetaxel—prostate cancer	0.000196	0.00114	CcSEcCtD
Dronedarone—Rash—Conjugated Estrogens—prostate cancer	0.000195	0.00114	CcSEcCtD
Dronedarone—Dermatitis—Conjugated Estrogens—prostate cancer	0.000195	0.00114	CcSEcCtD
Dronedarone—Anaphylactic shock—Etoposide—prostate cancer	0.000192	0.00112	CcSEcCtD
Dronedarone—Dysgeusia—Docetaxel—prostate cancer	0.000192	0.00112	CcSEcCtD
Dronedarone—Blood creatinine increased—Doxorubicin—prostate cancer	0.00019	0.00111	CcSEcCtD
Dronedarone—Erythema—Capecitabine—prostate cancer	0.00019	0.0011	CcSEcCtD
Dronedarone—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000189	0.0011	CcSEcCtD
Dronedarone—Skin disorder—Etoposide—prostate cancer	0.000187	0.00109	CcSEcCtD
Dronedarone—Nausea—Goserelin—prostate cancer	0.000186	0.00108	CcSEcCtD
Dronedarone—Dysgeusia—Capecitabine—prostate cancer	0.000186	0.00108	CcSEcCtD
Dronedarone—Hypokalaemia—Doxorubicin—prostate cancer	0.000185	0.00107	CcSEcCtD
Dronedarone—Nausea—Conjugated Estrogens—prostate cancer	0.000184	0.00107	CcSEcCtD
Dronedarone—Abdominal pain—Mitoxantrone—prostate cancer	0.000183	0.00106	CcSEcCtD
Dronedarone—Asthenia—Estradiol—prostate cancer	0.000178	0.00104	CcSEcCtD
Dronedarone—Angiopathy—Prednisone—prostate cancer	0.000176	0.00102	CcSEcCtD
Dronedarone—Pruritus—Estradiol—prostate cancer	0.000176	0.00102	CcSEcCtD
Dronedarone—Immune system disorder—Prednisone—prostate cancer	0.000175	0.00102	CcSEcCtD
Dronedarone—ABCB1—testis—prostate cancer	0.000175	0.00196	CbGeAlD
Dronedarone—Photosensitivity reaction—Epirubicin—prostate cancer	0.000173	0.00101	CcSEcCtD
Dronedarone—Pneumonia—Epirubicin—prostate cancer	0.00017	0.000989	CcSEcCtD
Dronedarone—Diarrhoea—Estradiol—prostate cancer	0.00017	0.000988	CcSEcCtD
Dronedarone—Erythema—Prednisone—prostate cancer	0.000169	0.000983	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Etoposide—prostate cancer	0.000166	0.000966	CcSEcCtD
Dronedarone—Asthenia—Mitoxantrone—prostate cancer	0.000166	0.000965	CcSEcCtD
Dronedarone—Fatigue—Etoposide—prostate cancer	0.000166	0.000965	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.000166	0.000964	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.00016	0.000933	CcSEcCtD
Dronedarone—Photosensitivity reaction—Doxorubicin—prostate cancer	0.00016	0.000932	CcSEcCtD
Dronedarone—Hepatobiliary disease—Epirubicin—prostate cancer	0.00016	0.00093	CcSEcCtD
Dronedarone—Anaphylactic shock—Docetaxel—prostate cancer	0.00016	0.00093	CcSEcCtD
Dronedarone—Diarrhoea—Mitoxantrone—prostate cancer	0.000158	0.000921	CcSEcCtD
Dronedarone—Vomiting—Estradiol—prostate cancer	0.000158	0.000918	CcSEcCtD
Dronedarone—Pneumonia—Doxorubicin—prostate cancer	0.000157	0.000915	CcSEcCtD
Dronedarone—Gastrointestinal pain—Etoposide—prostate cancer	0.000157	0.000915	CcSEcCtD
Dronedarone—Nervous system disorder—Docetaxel—prostate cancer	0.000157	0.000912	CcSEcCtD
Dronedarone—Rash—Estradiol—prostate cancer	0.000156	0.00091	CcSEcCtD
Dronedarone—Dermatitis—Estradiol—prostate cancer	0.000156	0.00091	CcSEcCtD
Dronedarone—Skin disorder—Docetaxel—prostate cancer	0.000155	0.000903	CcSEcCtD
Dronedarone—Bradycardia—Epirubicin—prostate cancer	0.000154	0.000899	CcSEcCtD
Dronedarone—Angioedema—Prednisone—prostate cancer	0.000154	0.000898	CcSEcCtD
Dronedarone—Abdominal pain—Etoposide—prostate cancer	0.000152	0.000885	CcSEcCtD
Dronedarone—Nervous system disorder—Capecitabine—prostate cancer	0.000152	0.000883	CcSEcCtD
Dronedarone—Skin disorder—Capecitabine—prostate cancer	0.00015	0.000875	CcSEcCtD
Dronedarone—Hepatobiliary disease—Doxorubicin—prostate cancer	0.000148	0.000861	CcSEcCtD
Dronedarone—Nausea—Estradiol—prostate cancer	0.000147	0.000858	CcSEcCtD
Dronedarone—Vomiting—Mitoxantrone—prostate cancer	0.000147	0.000855	CcSEcCtD
Dronedarone—Rash—Mitoxantrone—prostate cancer	0.000146	0.000848	CcSEcCtD
Dronedarone—Dermatitis—Mitoxantrone—prostate cancer	0.000146	0.000848	CcSEcCtD
Dronedarone—Bradycardia—Doxorubicin—prostate cancer	0.000143	0.000832	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.000143	0.000831	CcSEcCtD
Dronedarone—Cardiac disorder—Epirubicin—prostate cancer	0.000141	0.00082	CcSEcCtD
Dronedarone—Dyspepsia—Docetaxel—prostate cancer	0.000141	0.000819	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000138	0.000803	CcSEcCtD
Dronedarone—Asthenia—Etoposide—prostate cancer	0.000138	0.000803	CcSEcCtD
Dronedarone—Anaphylactic shock—Prednisone—prostate cancer	0.000138	0.000802	CcSEcCtD
Dronedarone—Fatigue—Docetaxel—prostate cancer	0.000138	0.000802	CcSEcCtD
Dronedarone—Angiopathy—Epirubicin—prostate cancer	0.000138	0.000801	CcSEcCtD
Dronedarone—Nausea—Mitoxantrone—prostate cancer	0.000137	0.000799	CcSEcCtD
Dronedarone—Immune system disorder—Epirubicin—prostate cancer	0.000137	0.000798	CcSEcCtD
Dronedarone—Mediastinal disorder—Epirubicin—prostate cancer	0.000137	0.000796	CcSEcCtD
Dronedarone—Dyspepsia—Capecitabine—prostate cancer	0.000136	0.000793	CcSEcCtD
Dronedarone—Pruritus—Etoposide—prostate cancer	0.000136	0.000792	CcSEcCtD
Dronedarone—Nervous system disorder—Prednisone—prostate cancer	0.000135	0.000787	CcSEcCtD
Dronedarone—Skin disorder—Prednisone—prostate cancer	0.000134	0.000779	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000134	0.000777	CcSEcCtD
Dronedarone—Fatigue—Capecitabine—prostate cancer	0.000133	0.000776	CcSEcCtD
Dronedarone—Erythema—Epirubicin—prostate cancer	0.000132	0.000769	CcSEcCtD
Dronedarone—Diarrhoea—Etoposide—prostate cancer	0.000132	0.000766	CcSEcCtD
Dronedarone—Gastrointestinal pain—Docetaxel—prostate cancer	0.000131	0.000761	CcSEcCtD
Dronedarone—Cardiac disorder—Doxorubicin—prostate cancer	0.00013	0.000758	CcSEcCtD
Dronedarone—Dysgeusia—Epirubicin—prostate cancer	0.000129	0.000753	CcSEcCtD
Dronedarone—Angiopathy—Doxorubicin—prostate cancer	0.000127	0.000741	CcSEcCtD
Dronedarone—ABCB1—lymph node—prostate cancer	0.000127	0.00142	CbGeAlD
Dronedarone—Immune system disorder—Doxorubicin—prostate cancer	0.000127	0.000738	CcSEcCtD
Dronedarone—Gastrointestinal pain—Capecitabine—prostate cancer	0.000127	0.000736	CcSEcCtD
Dronedarone—Mediastinal disorder—Doxorubicin—prostate cancer	0.000127	0.000736	CcSEcCtD
Dronedarone—Abdominal pain—Docetaxel—prostate cancer	0.000126	0.000735	CcSEcCtD
Dronedarone—Abdominal pain—Capecitabine—prostate cancer	0.000122	0.000712	CcSEcCtD
Dronedarone—Vomiting—Etoposide—prostate cancer	0.000122	0.000712	CcSEcCtD
Dronedarone—Erythema—Doxorubicin—prostate cancer	0.000122	0.000711	CcSEcCtD
Dronedarone—Dyspepsia—Prednisone—prostate cancer	0.000121	0.000706	CcSEcCtD
Dronedarone—Rash—Etoposide—prostate cancer	0.000121	0.000706	CcSEcCtD
Dronedarone—Dermatitis—Etoposide—prostate cancer	0.000121	0.000705	CcSEcCtD
Dronedarone—Dysgeusia—Doxorubicin—prostate cancer	0.00012	0.000697	CcSEcCtD
Dronedarone—Fatigue—Prednisone—prostate cancer	0.000119	0.000692	CcSEcCtD
Dronedarone—Asthenia—Docetaxel—prostate cancer	0.000115	0.000667	CcSEcCtD
Dronedarone—Nausea—Etoposide—prostate cancer	0.000114	0.000665	CcSEcCtD
Dronedarone—Pruritus—Docetaxel—prostate cancer	0.000113	0.000658	CcSEcCtD
Dronedarone—Gastrointestinal pain—Prednisone—prostate cancer	0.000113	0.000656	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	0.000112	0.00065	CcSEcCtD
Dronedarone—Asthenia—Capecitabine—prostate cancer	0.000111	0.000646	CcSEcCtD
Dronedarone—Pruritus—Capecitabine—prostate cancer	0.000109	0.000637	CcSEcCtD
Dronedarone—Diarrhoea—Docetaxel—prostate cancer	0.000109	0.000636	CcSEcCtD
Dronedarone—Abdominal pain—Prednisone—prostate cancer	0.000109	0.000634	CcSEcCtD
Dronedarone—Anaphylactic shock—Epirubicin—prostate cancer	0.000108	0.000627	CcSEcCtD
Dronedarone—Diarrhoea—Capecitabine—prostate cancer	0.000106	0.000616	CcSEcCtD
Dronedarone—Nervous system disorder—Epirubicin—prostate cancer	0.000106	0.000615	CcSEcCtD
Dronedarone—Skin disorder—Epirubicin—prostate cancer	0.000105	0.000609	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	0.000103	0.000601	CcSEcCtD
Dronedarone—Vomiting—Docetaxel—prostate cancer	0.000102	0.000591	CcSEcCtD
Dronedarone—Rash—Docetaxel—prostate cancer	0.000101	0.000586	CcSEcCtD
Dronedarone—Dermatitis—Docetaxel—prostate cancer	0.000101	0.000586	CcSEcCtD
Dronedarone—Anaphylactic shock—Doxorubicin—prostate cancer	9.97e-05	0.00058	CcSEcCtD
Dronedarone—Asthenia—Prednisone—prostate cancer	9.89e-05	0.000576	CcSEcCtD
Dronedarone—Vomiting—Capecitabine—prostate cancer	9.84e-05	0.000573	CcSEcCtD
Dronedarone—Nervous system disorder—Doxorubicin—prostate cancer	9.78e-05	0.000569	CcSEcCtD
Dronedarone—Rash—Capecitabine—prostate cancer	9.76e-05	0.000568	CcSEcCtD
Dronedarone—Pruritus—Prednisone—prostate cancer	9.75e-05	0.000568	CcSEcCtD
Dronedarone—Dermatitis—Capecitabine—prostate cancer	9.75e-05	0.000567	CcSEcCtD
Dronedarone—Skin disorder—Doxorubicin—prostate cancer	9.69e-05	0.000564	CcSEcCtD
Dronedarone—Nausea—Docetaxel—prostate cancer	9.49e-05	0.000552	CcSEcCtD
Dronedarone—Dyspepsia—Epirubicin—prostate cancer	9.49e-05	0.000552	CcSEcCtD
Dronedarone—Diarrhoea—Prednisone—prostate cancer	9.43e-05	0.000549	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Epirubicin—prostate cancer	9.31e-05	0.000542	CcSEcCtD
Dronedarone—Fatigue—Epirubicin—prostate cancer	9.29e-05	0.000541	CcSEcCtD
Dronedarone—Nausea—Capecitabine—prostate cancer	9.19e-05	0.000535	CcSEcCtD
Dronedarone—Gastrointestinal pain—Epirubicin—prostate cancer	8.81e-05	0.000513	CcSEcCtD
Dronedarone—Dyspepsia—Doxorubicin—prostate cancer	8.78e-05	0.000511	CcSEcCtD
Dronedarone—Vomiting—Prednisone—prostate cancer	8.76e-05	0.00051	CcSEcCtD
Dronedarone—Rash—Prednisone—prostate cancer	8.69e-05	0.000506	CcSEcCtD
Dronedarone—Dermatitis—Prednisone—prostate cancer	8.68e-05	0.000505	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Doxorubicin—prostate cancer	8.61e-05	0.000501	CcSEcCtD
Dronedarone—Fatigue—Doxorubicin—prostate cancer	8.6e-05	0.0005	CcSEcCtD
Dronedarone—Abdominal pain—Epirubicin—prostate cancer	8.52e-05	0.000496	CcSEcCtD
Dronedarone—Nausea—Prednisone—prostate cancer	8.19e-05	0.000476	CcSEcCtD
Dronedarone—Gastrointestinal pain—Doxorubicin—prostate cancer	8.16e-05	0.000475	CcSEcCtD
Dronedarone—Abdominal pain—Doxorubicin—prostate cancer	7.88e-05	0.000459	CcSEcCtD
Dronedarone—Asthenia—Epirubicin—prostate cancer	7.73e-05	0.00045	CcSEcCtD
Dronedarone—Pruritus—Epirubicin—prostate cancer	7.63e-05	0.000444	CcSEcCtD
Dronedarone—Diarrhoea—Epirubicin—prostate cancer	7.38e-05	0.000429	CcSEcCtD
Dronedarone—Asthenia—Doxorubicin—prostate cancer	7.16e-05	0.000416	CcSEcCtD
Dronedarone—Pruritus—Doxorubicin—prostate cancer	7.06e-05	0.000411	CcSEcCtD
Dronedarone—Vomiting—Epirubicin—prostate cancer	6.85e-05	0.000399	CcSEcCtD
Dronedarone—Diarrhoea—Doxorubicin—prostate cancer	6.82e-05	0.000397	CcSEcCtD
Dronedarone—Rash—Epirubicin—prostate cancer	6.8e-05	0.000396	CcSEcCtD
Dronedarone—Dermatitis—Epirubicin—prostate cancer	6.79e-05	0.000395	CcSEcCtD
Dronedarone—Nausea—Epirubicin—prostate cancer	6.4e-05	0.000373	CcSEcCtD
Dronedarone—Vomiting—Doxorubicin—prostate cancer	6.34e-05	0.000369	CcSEcCtD
Dronedarone—Rash—Doxorubicin—prostate cancer	6.29e-05	0.000366	CcSEcCtD
Dronedarone—Dermatitis—Doxorubicin—prostate cancer	6.28e-05	0.000366	CcSEcCtD
Dronedarone—Nausea—Doxorubicin—prostate cancer	5.92e-05	0.000345	CcSEcCtD
Dronedarone—ADRA1A—Signaling Pathways—SERPINE1—prostate cancer	1.83e-06	9.62e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—IL6—prostate cancer	1.82e-06	9.58e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—EP300—prostate cancer	1.82e-06	9.56e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CASP3—prostate cancer	1.82e-06	9.55e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—PIK3CB—prostate cancer	1.82e-06	9.55e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—MTHFR—prostate cancer	1.82e-06	9.54e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—IL2—prostate cancer	1.82e-06	9.54e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CREBBP—prostate cancer	1.81e-06	9.54e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.81e-06	9.53e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—KRAS—prostate cancer	1.81e-06	9.53e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—IL6—prostate cancer	1.81e-06	9.49e-06	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—EP300—prostate cancer	1.8e-06	9.48e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PIK3CB—prostate cancer	1.79e-06	9.42e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—IGF1—prostate cancer	1.79e-06	9.42e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CCND1—prostate cancer	1.79e-06	9.38e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—EGFR—prostate cancer	1.78e-06	9.37e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PPARA—prostate cancer	1.78e-06	9.36e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PTGS2—prostate cancer	1.78e-06	9.34e-06	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—CAV1—prostate cancer	1.78e-06	9.34e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CXCL8—prostate cancer	1.77e-06	9.32e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—FGF2—prostate cancer	1.77e-06	9.32e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.77e-06	9.31e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CCND1—prostate cancer	1.77e-06	9.3e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CTNNB1—prostate cancer	1.77e-06	9.29e-06	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—SRC—prostate cancer	1.75e-06	9.22e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CTNNB1—prostate cancer	1.75e-06	9.21e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—NQO1—prostate cancer	1.75e-06	9.21e-06	CbGpPWpGaD
Dronedarone—ALB—Metabolism—INS—prostate cancer	1.75e-06	9.19e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—NOS3—prostate cancer	1.75e-06	9.19e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CXCL8—prostate cancer	1.75e-06	9.18e-06	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—AKT1—prostate cancer	1.74e-06	9.14e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—MMP9—prostate cancer	1.73e-06	9.11e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CDKN1B—prostate cancer	1.73e-06	9.1e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MAP2K1—prostate cancer	1.73e-06	9.1e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CDKN1A—prostate cancer	1.73e-06	9.08e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—TH—prostate cancer	1.73e-06	9.07e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—PTEN—prostate cancer	1.72e-06	9.06e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PIK3CD—prostate cancer	1.72e-06	9.04e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—MMP9—prostate cancer	1.72e-06	9.03e-06	CbGpPWpGaD
Dronedarone—ADRA2C—GPCR downstream signaling—AKT1—prostate cancer	1.71e-06	9.01e-06	CbGpPWpGaD
Dronedarone—ALB—Metabolism—CREBBP—prostate cancer	1.71e-06	9e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CDKN1A—prostate cancer	1.71e-06	9e-06	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—VEGFA—prostate cancer	1.71e-06	8.98e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—PTEN—prostate cancer	1.71e-06	8.98e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CDKN1B—prostate cancer	1.71e-06	8.96e-06	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—PIK3CA—prostate cancer	1.7e-06	8.96e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—SERPINE1—prostate cancer	1.7e-06	8.94e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—JAK2—prostate cancer	1.7e-06	8.93e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CASP3—prostate cancer	1.7e-06	8.92e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—IL2—prostate cancer	1.7e-06	8.91e-06	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—STAT3—prostate cancer	1.69e-06	8.89e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—IL6—prostate cancer	1.69e-06	8.87e-06	CbGpPWpGaD
Dronedarone—ADRA1B—GPCR downstream signaling—AKT1—prostate cancer	1.69e-06	8.86e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—KRAS—prostate cancer	1.68e-06	8.85e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—AKT1—prostate cancer	1.68e-06	8.84e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.68e-06	8.83e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—CAV1—prostate cancer	1.67e-06	8.8e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CASP3—prostate cancer	1.67e-06	8.78e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—IL2—prostate cancer	1.67e-06	8.77e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—AKT1—prostate cancer	1.67e-06	8.76e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—PIK3CA—prostate cancer	1.67e-06	8.75e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—IL6—prostate cancer	1.66e-06	8.73e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MDM2—prostate cancer	1.66e-06	8.72e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CCND1—prostate cancer	1.65e-06	8.69e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—FGF2—prostate cancer	1.65e-06	8.66e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—EP300—prostate cancer	1.64e-06	8.64e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CTNNB1—prostate cancer	1.64e-06	8.6e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—ERBB2—prostate cancer	1.64e-06	8.59e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—EP300—prostate cancer	1.63e-06	8.56e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GGT1—prostate cancer	1.63e-06	8.55e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CCND1—prostate cancer	1.63e-06	8.55e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—NOS3—prostate cancer	1.62e-06	8.54e-06	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PIK3CD—prostate cancer	1.62e-06	8.53e-06	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PIK3CG—prostate cancer	1.62e-06	8.51e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—PIK3CB—prostate cancer	1.61e-06	8.48e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CTNNB1—prostate cancer	1.61e-06	8.47e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—MMP9—prostate cancer	1.6e-06	8.43e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—NCOA1—prostate cancer	1.6e-06	8.42e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CDKN1A—prostate cancer	1.6e-06	8.4e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—SRC—prostate cancer	1.6e-06	8.4e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—PTEN—prostate cancer	1.6e-06	8.38e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—SRC—prostate cancer	1.58e-06	8.32e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—MMP9—prostate cancer	1.58e-06	8.3e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.58e-06	8.3e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—JAK2—prostate cancer	1.58e-06	8.3e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CDKN1A—prostate cancer	1.57e-06	8.27e-06	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—MYC—prostate cancer	1.57e-06	8.26e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—PTEN—prostate cancer	1.57e-06	8.25e-06	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—TGFB1—prostate cancer	1.57e-06	8.24e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—VEGFA—prostate cancer	1.56e-06	8.18e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—AKT1—prostate cancer	1.56e-06	8.18e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CXCL8—prostate cancer	1.55e-06	8.15e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PTEN—prostate cancer	1.55e-06	8.14e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—PIK3CA—prostate cancer	1.55e-06	8.13e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—VEGFA—prostate cancer	1.54e-06	8.11e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—STAT3—prostate cancer	1.54e-06	8.1e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MDM2—prostate cancer	1.54e-06	8.1e-06	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—EGFR—prostate cancer	1.54e-06	8.08e-06	CbGpPWpGaD
Dronedarone—ALB—Metabolism—NOS3—prostate cancer	1.53e-06	8.06e-06	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—INS—prostate cancer	1.53e-06	8.05e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—AKT1—prostate cancer	1.53e-06	8.05e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—STAT3—prostate cancer	1.53e-06	8.03e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.53e-06	8.01e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—RXRA—prostate cancer	1.52e-06	8.01e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—EP300—prostate cancer	1.52e-06	8e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—ERBB2—prostate cancer	1.52e-06	7.99e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CDKN1B—prostate cancer	1.51e-06	7.96e-06	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—CREBBP—prostate cancer	1.5e-06	7.89e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PIK3CB—prostate cancer	1.5e-06	7.88e-06	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR downstream signaling—AKT1—prostate cancer	1.5e-06	7.87e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—EP300—prostate cancer	1.5e-06	7.87e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CASP3—prostate cancer	1.48e-06	7.8e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—IL2—prostate cancer	1.48e-06	7.79e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—SRC—prostate cancer	1.48e-06	7.77e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—EP300—prostate cancer	1.48e-06	7.77e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—IL6—prostate cancer	1.47e-06	7.75e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—COMT—prostate cancer	1.47e-06	7.72e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GSTP1—prostate cancer	1.46e-06	7.68e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—SRC—prostate cancer	1.46e-06	7.65e-06	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—KRAS—prostate cancer	1.45e-06	7.63e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CCND1—prostate cancer	1.45e-06	7.59e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—INS—prostate cancer	1.44e-06	7.59e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CXCL8—prostate cancer	1.44e-06	7.57e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—VEGFA—prostate cancer	1.44e-06	7.57e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—ITPR1—prostate cancer	1.44e-06	7.56e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—MYC—prostate cancer	1.43e-06	7.53e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CTNNB1—prostate cancer	1.43e-06	7.52e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—TGFB1—prostate cancer	1.43e-06	7.51e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—STAT3—prostate cancer	1.43e-06	7.5e-06	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PIK3CD—prostate cancer	1.42e-06	7.48e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—MYC—prostate cancer	1.42e-06	7.46e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—VEGFA—prostate cancer	1.42e-06	7.45e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—TGFB1—prostate cancer	1.42e-06	7.44e-06	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PIK3CB—prostate cancer	1.42e-06	7.44e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—CREBBP—prostate cancer	1.41e-06	7.43e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CDKN1B—prostate cancer	1.41e-06	7.4e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—STAT3—prostate cancer	1.4e-06	7.38e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MMP9—prostate cancer	1.4e-06	7.37e-06	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PTGS2—prostate cancer	1.4e-06	7.37e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—EGFR—prostate cancer	1.4e-06	7.36e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CDKN1A—prostate cancer	1.4e-06	7.35e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—PTEN—prostate cancer	1.39e-06	7.33e-06	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—AKT1—prostate cancer	1.39e-06	7.32e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—EGFR—prostate cancer	1.39e-06	7.3e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CASP3—prostate cancer	1.38e-06	7.25e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—IL2—prostate cancer	1.38e-06	7.24e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—IL6—prostate cancer	1.37e-06	7.2e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—AKT1—prostate cancer	1.36e-06	7.15e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—TYMS—prostate cancer	1.36e-06	7.14e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—PIK3CA—prostate cancer	1.35e-06	7.07e-06	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—NOS3—prostate cancer	1.34e-06	7.06e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GSTM1—prostate cancer	1.34e-06	7.06e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CCND1—prostate cancer	1.34e-06	7.06e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.34e-06	7.05e-06	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—PIK3CA—prostate cancer	1.33e-06	7.01e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—EP300—prostate cancer	1.33e-06	6.99e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CTNNB1—prostate cancer	1.33e-06	6.99e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—MYC—prostate cancer	1.33e-06	6.97e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—KRAS—prostate cancer	1.32e-06	6.96e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—TGFB1—prostate cancer	1.32e-06	6.95e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—LPL—prostate cancer	1.32e-06	6.93e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—KRAS—prostate cancer	1.31e-06	6.89e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—MYC—prostate cancer	1.3e-06	6.86e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MMP9—prostate cancer	1.3e-06	6.85e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—TGFB1—prostate cancer	1.3e-06	6.84e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CDKN1A—prostate cancer	1.3e-06	6.83e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—EGFR—prostate cancer	1.3e-06	6.81e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PTEN—prostate cancer	1.3e-06	6.81e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—SRC—prostate cancer	1.29e-06	6.8e-06	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—TP53—prostate cancer	1.29e-06	6.78e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—EGFR—prostate cancer	1.28e-06	6.71e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.27e-06	6.69e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—NOS3—prostate cancer	1.27e-06	6.65e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—AKT1—prostate cancer	1.26e-06	6.64e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—ERCC2—prostate cancer	1.26e-06	6.63e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—VEGFA—prostate cancer	1.26e-06	6.62e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—STAT3—prostate cancer	1.25e-06	6.55e-06	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PIK3CB—prostate cancer	1.24e-06	6.52e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—EP300—prostate cancer	1.24e-06	6.49e-06	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PTGS2—prostate cancer	1.23e-06	6.46e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—KRAS—prostate cancer	1.23e-06	6.44e-06	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PTEN—prostate cancer	1.22e-06	6.43e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—PIK3CA—prostate cancer	1.22e-06	6.39e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—KRAS—prostate cancer	1.21e-06	6.34e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—PIK3CA—prostate cancer	1.2e-06	6.33e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—SRC—prostate cancer	1.2e-06	6.32e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—MTHFR—prostate cancer	1.19e-06	6.24e-06	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—IL6—prostate cancer	1.18e-06	6.21e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—TP53—prostate cancer	1.18e-06	6.18e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—VEGFA—prostate cancer	1.17e-06	6.15e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.17e-06	6.14e-06	CbGpPWpGaD
Dronedarone—ALB—Metabolism—EP300—prostate cancer	1.17e-06	6.13e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—TP53—prostate cancer	1.17e-06	6.13e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PPARA—prostate cancer	1.16e-06	6.12e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MYC—prostate cancer	1.16e-06	6.09e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—STAT3—prostate cancer	1.16e-06	6.09e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PTGS2—prostate cancer	1.16e-06	6.08e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—TGFB1—prostate cancer	1.16e-06	6.08e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—EGFR—prostate cancer	1.13e-06	5.96e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—PIK3CA—prostate cancer	1.13e-06	5.91e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—PIK3CA—prostate cancer	1.11e-06	5.82e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—AKT1—prostate cancer	1.1e-06	5.78e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CAV1—prostate cancer	1.09e-06	5.75e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PIK3CA—prostate cancer	1.09e-06	5.75e-06	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—AKT1—prostate cancer	1.09e-06	5.73e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—TP53—prostate cancer	1.09e-06	5.72e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MYC—prostate cancer	1.08e-06	5.66e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—IL6—prostate cancer	1.08e-06	5.66e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—TGFB1—prostate cancer	1.07e-06	5.65e-06	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PTEN—prostate cancer	1.07e-06	5.63e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—TP53—prostate cancer	1.07e-06	5.63e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—KRAS—prostate cancer	1.07e-06	5.63e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—IL6—prostate cancer	1.07e-06	5.61e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—EGFR—prostate cancer	1.05e-06	5.54e-06	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—EP300—prostate cancer	1.02e-06	5.37e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PTEN—prostate cancer	1.01e-06	5.31e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PIK3CG—prostate cancer	9.97e-07	5.24e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—IL6—prostate cancer	9.97e-07	5.24e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—KRAS—prostate cancer	9.95e-07	5.23e-06	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—AKT1—prostate cancer	9.93e-07	5.22e-06	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—AKT1—prostate cancer	9.84e-07	5.17e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—PIK3CA—prostate cancer	9.84e-07	5.17e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—IL6—prostate cancer	9.81e-07	5.15e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—EP300—prostate cancer	9.63e-07	5.06e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—TP53—prostate cancer	9.52e-07	5e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—INS—prostate cancer	9.44e-07	4.96e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CREBBP—prostate cancer	9.25e-07	4.86e-06	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—AKT1—prostate cancer	9.2e-07	4.83e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PIK3CA—prostate cancer	9.14e-07	4.8e-06	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—AKT1—prostate cancer	9.05e-07	4.76e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—AKT1—prostate cancer	8.93e-07	4.69e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—TP53—prostate cancer	8.84e-07	4.65e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PIK3CD—prostate cancer	8.77e-07	4.61e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—IL6—prostate cancer	8.71e-07	4.58e-06	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PIK3CA—prostate cancer	8.63e-07	4.53e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—NOS3—prostate cancer	8.28e-07	4.35e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—IL6—prostate cancer	8.1e-07	4.25e-06	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—AKT1—prostate cancer	8.04e-07	4.22e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PIK3CB—prostate cancer	7.64e-07	4.02e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PTGS2—prostate cancer	7.57e-07	3.98e-06	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PIK3CA—prostate cancer	7.56e-07	3.97e-06	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—AKT1—prostate cancer	7.47e-07	3.92e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PIK3CA—prostate cancer	7.12e-07	3.74e-06	CbGpPWpGaD
Dronedarone—ALB—Metabolism—AKT1—prostate cancer	7.05e-07	3.7e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PTEN—prostate cancer	6.6e-07	3.47e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—EP300—prostate cancer	6.3e-07	3.31e-06	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—AKT1—prostate cancer	6.18e-07	3.25e-06	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—AKT1—prostate cancer	5.82e-07	3.06e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PIK3CA—prostate cancer	4.66e-07	2.45e-06	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—AKT1—prostate cancer	3.81e-07	2e-06	CbGpPWpGaD
